✅ TN-IMS Thyroid Cancer Surgery Device: Clinical Trial Results Published

Focus Keyword: TN-IMS thyroid cancer surgery

We are excited to announce that the TN-IMS thyroid cancer surgery device has reached a groundbreaking milestone in the field of surgical oncology. A newly published peer-reviewed clinical study in Surgery Today (Springer Nature, 2025) confirms the device’s safety, accuracy, and clinical potential. This milestone places TN-IMS at the forefront of real-time diagnostic tools for thyroid cancer surgeries.

🚀 What is TN-IMS?

TN-IMS (Thyroid Node – Impedimetric Mapping System) is an innovative, intraoperative diagnostic tool developed to help surgeons detect malignancy in cervical lymph nodes during thyroid cancer surgery. Based on Electrical Lymph-Node Scanning (ELS), it measures tissue impedance characteristics through dual electrodes to determine if lymph nodes are cancerous—all in less than one minute.

Traditional techniques like frozen section and ultrasound have major limitations in intraoperative decision-making. TN-IMS solves this by providing real-time impedance-based measurements that support accurate, on-the-spot clinical judgments.

📊 Clinical Results: Published and Peer-Reviewed

The study, involving 36 patients and 109 suspicious lymph nodes, demonstrated exceptional diagnostic performance. Compared with the gold standard of permanent pathology, TN-IMS achieved:

• ✅ 90% Sensitivity
• ✅ 94.9% Specificity
• ✅ 93.6% Accuracy
• ✅ 96.2% Positive Predictive Value (PPV)
• ✅ 87.1% Negative Predictive Value (NPV)

These results make TN-IMS one of the most effective intraoperative tools currently available for thyroid cancer management. Surgeons now have a way to verify malignancy intraoperatively without waiting for external pathology reports.

📘 Read the Full Paper in Surgery Today

DOC-20250403-WA0092. (1)

🔬 How TN-IMS Works

The system uses two medical-grade electrodes: one placed under the skin (a surface pad), and one needle inserted into the suspicious lymph node. These connect wirelessly via a handheld probe to the TN-IMS device, which interprets tissue impedance signals and returns a “Positive” or “Negative” result for malignancy. This unique system reduces guesswork and eliminates the need for unnecessary dissections.

By making surgeries more accurate and personalized, the TN-IMS thyroid cancer surgery device has the potential to lower complication rates and improve patient outcomes.

👩‍⚕️ Who Benefits from TN-IMS?

TN-IMS is ideal for:

• Endocrine surgeons handling complex thyroid nodules
• Head & neck cancer surgeons
• ENT specialists involved in neck dissections
• Hospitals aiming for precision-based surgery
• Clinical research centers conducting oncology trials

It’s particularly powerful in handling Bethesda III–VI and TI-RADS 4–5 cases—where traditional diagnostic options fall short.

💼 Global Opportunities & Next Steps

Following this clinical success, we are actively seeking:

• Distribution partners across Europe, Asia, and the Middle East
• Hospitals for multi-center validation studies
• Investment in CE certification and market expansion

We also plan to launch an ultrasound-compatible version of TN-IMS for preoperative diagnostics soon, making it even more versatile across patient care stages.

📩 Contact & Collaboration

• Email: headofboard@hospital-tech.com
• Website: www.hospital-tech.com
• Schedule a live demo or request a full clinical dossier

#TNIMS #ThyroidCancer #CancerSurgery #ThyroidSurgery #OncologyDevices #IntraoperativeDiagnostics #MedicalInnovation #BethesdaNodules #HeadNeckSurgery #RealTimeCancerDetection